This page is listing influenza pandemic preparedness plans for EU countries, EFTA countries, Candidate countries and from the Commission of the European Communities and the World Health Organization.
A pandemic is the rapid spread of a new human influenza around the world. Influenza pandemics happen when a new strain of a flu virus appears which can infect humans, to which most people have no immunity and which can transmit efficiently from human to human.
This systematic review and meta-analysis of observational data from an established group of specialists assessed treatment outcomes for all three neuraminidase inhibitors (NAIs); oseltamivir, zanamivir and peramivir given to hospitalised patients with influenza A(H1N1)pdm09 during the 2009 pandemic.
During the 1918-1920 influenza pandemic all populations experienced an increase in influenza related deaths. However that mortality varied considerably between different locations and demographic subgroups.
This small study performed at two tertiary care teaching hospitals in New York, compares and evaluates the risk of Influenza A (H1N1) pdm09 infection among front line health care professionals and non health care professionals in the 2009 pandemic.
Following a meeting of the global influenza collaborating centres in Beijing hosted by the newest Centre that in China the World Health Organization (WHO) recently recommended that influenza vaccines to be used in the 2013 Southern Hemisphere (SH) influenza season should contain the same three strains as the vaccines that now are being used in the Northern Hemisphere (NH).
In September 2010 Sweden and Finland noted a number of children had developed narcolepsy seemingly in association with having received the pandemic vaccine used almost exclusively in those countries (Pandemrix)
Antiviral susceptibility is a key area for influenza surveillance as it can affect patient management, prevention of outbreaks and pandemic preparedness.